[go: up one dir, main page]

FI885094A7 - Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi

Info

Publication number
FI885094A7
FI885094A7 FI885094A FI885094A FI885094A7 FI 885094 A7 FI885094 A7 FI 885094A7 FI 885094 A FI885094 A FI 885094A FI 885094 A FI885094 A FI 885094A FI 885094 A7 FI885094 A7 FI 885094A7
Authority
FI
Finland
Prior art keywords
fluoropyrimidine
dideoxy
preparing
therapeutically useful
purine nucleoside
Prior art date
Application number
FI885094A
Other languages
English (en)
Swedish (sv)
Other versions
FI91763B (fi
FI885094A0 (fi
FI91763C (fi
Inventor
Charlene Louise Burns
Susan Mary Daluge
George Walter Koszalka
Thomas Anthony Krenitsky
Tuttle Joel Van
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI885094A0 publication Critical patent/FI885094A0/fi
Publication of FI885094A7 publication Critical patent/FI885094A7/fi
Publication of FI91763B publication Critical patent/FI91763B/fi
Application granted granted Critical
Publication of FI91763C publication Critical patent/FI91763C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI885094A 1987-11-07 1988-11-04 Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi FI91763C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878726136A GB8726136D0 (en) 1987-11-07 1987-11-07 Therapeutic nucleosides
GB8726136 1987-11-07

Publications (4)

Publication Number Publication Date
FI885094A0 FI885094A0 (fi) 1988-11-04
FI885094A7 true FI885094A7 (fi) 1989-05-08
FI91763B FI91763B (fi) 1994-04-29
FI91763C FI91763C (fi) 1994-08-10

Family

ID=10626612

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885094A FI91763C (fi) 1987-11-07 1988-11-04 Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi

Country Status (17)

Country Link
US (1) US5574149A (fi)
EP (3) EP0670328A1 (fi)
JP (1) JP2731551B2 (fi)
KR (1) KR890008160A (fi)
AT (1) ATE131826T1 (fi)
AU (1) AU616914B2 (fi)
CA (1) CA1333391C (fi)
DE (1) DE3854811T2 (fi)
DK (1) DK615788A (fi)
ES (1) ES2081286T3 (fi)
FI (1) FI91763C (fi)
GB (1) GB8726136D0 (fi)
GR (1) GR3019379T3 (fi)
HU (2) HU204839B (fi)
MX (1) MX9203217A (fi)
PT (1) PT88948B (fi)
ZA (1) ZA888289B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506215A (en) * 1987-11-03 1996-04-09 Medivir Ab 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides
US5157114A (en) * 1988-08-19 1992-10-20 Burroughs Wellcome Co. 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
WO1990003978A1 (en) * 1988-10-03 1990-04-19 Stichting Rega Vzw 5-halogeno-3'-fluoro-2',3'-dideoxyuridine compounds and their therapeutic application
JPH05501404A (ja) * 1989-11-06 1993-03-18 ニユコメド・アクシエセルカペト ヌクレオシド誘導体
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
DE69324244T2 (de) * 1992-01-06 1999-09-30 The Wellcome Foundation Ltd., Greenford Therapeutische nukleoside der 2',3'-dideoxy-3'-fluor -purin reihe
GB9200150D0 (en) * 1992-01-06 1992-02-26 Wellcome Found Therapeutic nucleosides
JPH08508489A (ja) * 1993-03-31 1996-09-10 スターリング ウィンスロップ インコーポレイティド 二官能価ヌクレオシド、それらのオリゴマーならびにそれらの製造方法及び使用方法
ATE169027T1 (de) * 1993-05-12 1998-08-15 Rhodia Limited Herstellung von fluoro-nukleosiden und dafür geeignete zwischenprodukte
ATE220558T1 (de) * 1997-11-22 2002-08-15 Roche Diagnostics Gmbh Verbessertes verfahren zur stabilisierung von proteinen
US6156349A (en) * 1998-12-14 2000-12-05 Steinbach, Pylant And Herman, L.L.C. Method of treating HIV infection with suppository containing mammalian liver extract
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
AU2002322325A1 (en) * 2001-06-22 2003-01-08 Emory University Beta-2'-or 3'-halonucleosides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328388A (en) * 1964-09-02 1967-06-27 Merck & Co Inc Arabinofuranosyl pyrimidines and methods of preparing same
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
US5153180A (en) * 1986-07-24 1992-10-06 Eckart Matthes Fluorinated nucleosides and process for treating retrovirus infections therewith
DD279407A1 (de) * 1986-07-24 1990-06-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines mittels gegen aids
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy

Also Published As

Publication number Publication date
ES2081286T3 (es) 1996-03-01
DK615788D0 (da) 1988-11-04
ATE131826T1 (de) 1996-01-15
HU200931B (en) 1990-09-28
EP0317128A2 (en) 1989-05-24
EP0670328A1 (en) 1995-09-06
EP0317128A3 (en) 1991-10-02
ZA888289B (en) 1990-07-25
US5574149A (en) 1996-11-12
HU902123D0 (en) 1990-07-28
FI91763B (fi) 1994-04-29
DE3854811T2 (de) 1996-08-01
KR890008160A (ko) 1989-07-10
PT88948A (pt) 1988-12-01
PT88948B (pt) 1993-02-26
FI885094A0 (fi) 1988-11-04
MX9203217A (es) 1992-07-01
EP0669341A1 (en) 1995-08-30
HU204839B (en) 1992-02-28
AU616914B2 (en) 1991-11-14
DK615788A (da) 1989-05-08
HUT48466A (en) 1989-06-28
AU2476388A (en) 1989-05-25
FI91763C (fi) 1994-08-10
GR3019379T3 (en) 1996-06-30
DE3854811D1 (de) 1996-02-01
EP0317128B1 (en) 1995-12-20
CA1333391C (en) 1994-12-06
JPH01153697A (ja) 1989-06-15
GB8726136D0 (en) 1987-12-09
JP2731551B2 (ja) 1998-03-25

Similar Documents

Publication Publication Date Title
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI890286A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten dideoksikarbosyklisten nukleosidianalogien valmistamiseksi
PT86660A (pt) Process for preparing adenosine 5:-carboxamide derivatives
DE3856154D1 (de) Adenosin-Derivate
FI883426L (fi) Menetelmä terapeuttisesti käyttökelpoisen pentasakkaridin valmistamiseksi
FI885153L (fi) Menetelmä terapeuttisesti aktiivisten 2',3'-dideoksi-2'-fluorinukleosidien valmistamiseksi
FI883603A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI873350A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI884627A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten dideoksisytidiinijohdannaisten valmistamiseksi
FI885094A7 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi
NO179908C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, carbocykliske adenosinanaloger
FI890028A7 (fi) Menetelmä 2-substituoitujen adenosiinijohdannaisten valmistamiseksi
FI883889A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi
KR860005574A (ko) 뉴클레오시드 유도체의 제조방법
FI891339A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi
FI880467A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI883672A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
NZ235534A (en) 3'-azido-2',3'-dideoxy purine derivatives
FI884660L (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
NO884830L (no) Purin-derivater.
KR860004919A (ko) 뉴클레오시드 유도체의 제조방법
FI884473A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI885045L (fi) Menetelmä polynukleotidien valmistamiseksi
FI883248A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3,5-dihydroksikarboksyylihappojohdannaisten valmistamiseksi
PT87605A (pt) Process for the preparation of the (s)-isomer of a purine derivative

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED